These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25839898)

  • 61. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice.
    Ruiz-DeDiego I; Mellstrom B; Vallejo M; Naranjo JR; Moratalla R
    Biol Psychiatry; 2015 Jan; 77(2):95-105. PubMed ID: 24857398
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Parul ; Shukla S
    Neurochem Int; 2019 Jan; 122():170-186. PubMed ID: 30500462
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
    Yin LL; Geng XC; Zhu XZ
    Brain Res Bull; 2011 Nov; 86(5-6):367-72. PubMed ID: 21963945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of bupropion and pramipexole on cell proliferation in the hippocampus of adrenocorticotropic hormone-treated rats.
    Onoue Y; Kuwatsuka K; Miyazaki I; Asanuma M; Kitamura Y; Sendo T
    Biol Pharm Bull; 2014; 37(2):327-30. PubMed ID: 24492730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MT
    Noseda ACD; Rodrigues LS; Targa ADS; Ilkiw JL; Fagotti J; Dos Santos PD; Cecon E; Markus RP; Solimena M; Jockers R; Lima MMS
    Eur J Pharmacol; 2021 Jan; 891():173722. PubMed ID: 33159932
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
    Ermine CM; Wright JL; Frausin S; Kauhausen JA; Parish CL; Stanic D; Thompson LH
    Hippocampus; 2018 May; 28(5):327-337. PubMed ID: 29431270
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
    Borah A; Mohanakumar KP
    Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760
    [TBL] [Abstract][Full Text] [Related]  

  • 69. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
    Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
    Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.
    Chao OY; Mattern C; Silva AM; Wessler J; Ruocco LA; Nikolaus S; Huston JP; Pum ME
    Brain Res Bull; 2012 Feb; 87(2-3):340-5. PubMed ID: 22108632
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Shimizu M; Tanaka K; Ogawa N
    Neurol Res; 2005 Jul; 27(5):533-9. PubMed ID: 15978181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata.
    Yamamoto N; Pierce RC; Soghomonian JJ
    Brain Res; 2006 Dec; 1123(1):196-200. PubMed ID: 17027936
    [TBL] [Abstract][Full Text] [Related]  

  • 75. L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.
    Bonaventura J; Rico AJ; Moreno E; Sierra S; Sánchez M; Luquin N; Farré D; Müller CE; Martínez-Pinilla E; Cortés A; Mallol J; Armentero MT; Pinna A; Canela EI; Lluís C; McCormick PJ; Lanciego JL; Casadó V; Franco R
    Neuropharmacology; 2014 Apr; 79():90-100. PubMed ID: 24230991
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons.
    Marin C; Laxe S; Langdon C; Alobid I; Berenguer J; Fuentes M; Bernabeu M; Mullol J
    Mol Neurobiol; 2019 Dec; 56(12):8063-8075. PubMed ID: 31177483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis.
    Pérez-Domper P; Palomo V; Gradari S; Gil C; de Ceballos ML; Martínez A; Trejo JL
    Neuropharmacology; 2017 Apr; 116():174-187. PubMed ID: 28012947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice.
    Fuchigami T; Itokazu Y; Morgan JC; Yu RK
    Mol Neurobiol; 2023 Jun; 60(6):3329-3344. PubMed ID: 36849668
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
    Niyomrat K; Cheaha D; Nukitram J; Kumarnsit E
    Neurosci Lett; 2021 Aug; 759():136007. PubMed ID: 34098022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hericium erinaceus Extract Reduces Anxiety and Depressive Behaviors by Promoting Hippocampal Neurogenesis in the Adult Mouse Brain.
    Ryu S; Kim HG; Kim JY; Kim SY; Cho KO
    J Med Food; 2018 Feb; 21(2):174-180. PubMed ID: 29091526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.